📣 VC round data is live. Check it out!

Nanosonics Valuation Multiples

Discover revenue and EBITDA valuation multiples for Nanosonics and similar public comparables like MedicalSystem Technology, Advanced Medical Solutions Group, Bioventus, Synektik and more.

Nanosonics Overview

About Nanosonics

Nanosonics is largely a single-product firm, and its Trophon device provides high-level disinfection of ultrasound probes used in semicritical procedures. The patented technology uses low-temperature sonically activated hydrogen peroxide mist suitable for probes sensitive to damage. Automated HLD is increasingly being used as the standard of care globally as it is superior in preventing cross-infection of patients. Nanosonics’ revenue consists of capital sales of Trophon units, ongoing consumables sales, and service revenue. By December 2025, there were 38,000 Trophon units installed globally. Market penetration rates range from over 75% in Australia and New Zealand, over 50% in the US to single-digit penetration in Europe, Middle East, and Africa, and elsewhere in the Asia-Pacific region.


Founded

2000

HQ

Australia

Employees

470

Financials (LTM)

Revenue: $150M
EBITDA: $17M

EV

$591M

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Nanosonics Financials

Nanosonics reported last 12-month revenue of $150M and EBITDA of $17M.

In the same LTM period, Nanosonics generated $114M in gross profit, $17M in EBITDA, and $13M in net income.

Revenue (LTM)


Nanosonics P&L

In the most recent fiscal year, Nanosonics reported revenue of $143M and EBITDA of $23M.

Nanosonics is profitable as of last fiscal year, with gross margin of 78%, EBITDA margin of 16%, and net margin of 10%.

See analyst estimates for Nanosonics
LTMLast FY202320242025202620272028
Revenue$150M$143M$122M$133M$148M
Gross Profit$114M$112M$96M$104M$114M
Gross Margin76%78%78%78%77%
EBITDA$17M$23M$18M$19M$20M
EBITDA Margin11%16%15%14%14%
EBIT Margin7%8%3%3%6%
Net Profit$13M$15M$12M$12M$14M
Net Margin8%10%10%9%9%

Financial data powered by Morningstar, Inc.

Nanosonics Stock Performance

Nanosonics has current market cap of $702M, and enterprise value of $591M.

Market Cap Evolution


Nanosonics' stock price is $2.35.

Nanosonics share price decreased by 5.1% in the last 30 days, and by 26.1% in the last year.

Nanosonics has an EPS (earnings per share) of $0.05.

See more trading valuation data for Nanosonics
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$591M$702M0.8%-5.1%-4.3%-26.1%$0.05

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Nanosonics Valuation Multiples

Nanosonics trades at 4.0x EV/Revenue multiple, and 34.6x EV/EBITDA.

See NTM and 2027E valuation multiples for Nanosonics

EV / Revenue (LTM)


Nanosonics Financial Valuation Multiples

As of May 7, 2026, Nanosonics has market cap of $702M and EV of $591M.

Nanosonics has a P/E ratio of 55.9x.

LTMLast FY202320242025202620272028
EV/Revenue4.0x4.1x4.8x4.4x4.0x
EV/EBITDA34.6x25.8x32.1x30.7x29.5x
EV/EBIT55.5x50.8x141.3x169.6x69.9x
EV/Gross Profit5.2x5.3x6.2x5.7x5.2x
P/E55.9x47.1x59.3x57.9x51.4x
EV/FCF59.3x23.3x41.0x29.6x35.5x

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Nanosonics Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Nanosonics Margins & Growth Rates

Nanosonics grew revenue by 7% but EBITDA decreased by 25% in the last fiscal year.

In the most recent fiscal year, Nanosonics reported gross margin of 78%, EBITDA margin of 16%, and net margin of 10%.

See estimated margins and future growth rates for Nanosonics

Nanosonics Margins

Last FY202420252026202720282029
Gross Margin78%78%77%76%
EBITDA Margin16%14%14%13%
EBIT Margin8%3%6%8%
Net Margin10%9%9%9%
FCF Margin18%15%11%6%

Nanosonics Growth Rates

FY+1/FY23/2424/2525/2626/2727/2828/29
Revenue Growth7%9%11%8%
Gross Profit Growth4%9%10%7%
EBITDA Growth(25%)5%4%1%
EBIT Growth(10%)(17%)143%57%
Net Profit Growth(17%)2%13%6%
FCF Growth(69%)39%(17%)(40%)

Data powered by FactSet, Inc. and Morningstar, Inc.

Nanosonics Operational KPIs

Nanosonics' revenue per employee in the last FY averaged $0.3M, while opex per employee averaged $0.2M for the same period.

Nanosonics' Rule of 40 is 21% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Nanosonics' Rule of X is 33% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Access forward-looking KPIs for Nanosonics
LTMLast FY202320242025202620272028
Rule of 4022%21%
Bessemer Rule of X39%33%
Revenue per Employee$0.3M
Opex per Employee$0.2M
S&M Expenses to Revenue36%37%37%35%
G&A Expenses to Revenue42%43%15%16%16%
R&D Expenses to Revenue16%17%18%18%17%
Opex to Revenue74%75%76%71%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Nanosonics Competitors

Nanosonics competitors include MedicalSystem Technology, Advanced Medical Solutions Group, Bioventus, Synektik, Sunmax Biotechnology, BrainsWay, Alpha Tau Medical, SD Biosensor, MedCap and CeriBell.

Most Nanosonics public comparables operate across Medical Devices, DeepTech and HealthTech.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
MedicalSystem Technology14.9x13.5x50.5x60.4x
Advanced Medical Solutions Group3.3x2.5x19.7x11.4x
Bioventus1.7x1.7x9.7x8.2x
Synektik2.9x2.6x11.9x10.4x
Sunmax Biotechnology9.9x17.9x
BrainsWay11.4x10.4x60.4x63.8x
Alpha Tau Medical1334.8x(14.4x)(13.2x)
SD Biosensor1.2x(1.2x)

This data is available for Pro users. Sign up to see all Nanosonics competitors and their valuation data.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Nanosonics

When was Nanosonics founded?Nanosonics was founded in 2000.
Where is Nanosonics headquartered?Nanosonics is headquartered in Australia.
How many employees does Nanosonics have?As of today, Nanosonics has over 470 employees.
Who is the CEO of Nanosonics?Nanosonics' CEO is Michael Kavanagh.
Is Nanosonics publicly listed?Yes, Nanosonics is a public company listed on Australian Securities Exchange.
What is the stock symbol of Nanosonics?Nanosonics trades under NAN ticker.
When did Nanosonics go public?Nanosonics went public in 2007.
Who are competitors of Nanosonics?Nanosonics main competitors include MedicalSystem Technology, Advanced Medical Solutions Group, Bioventus, Synektik, Sunmax Biotechnology, BrainsWay, Alpha Tau Medical, SD Biosensor, MedCap, CeriBell.
What is the current market cap of Nanosonics?Nanosonics' current market cap is $702M.
What is the current revenue of Nanosonics?Nanosonics' last 12 months revenue is $150M.
What is the current revenue growth of Nanosonics?Nanosonics revenue growth (NTM/LTM) is 11%.
What is the current EV/Revenue multiple of Nanosonics?Current revenue multiple of Nanosonics is 4.0x.
Is Nanosonics profitable?Yes, Nanosonics is EBITDA-positive (as of the last 12 months).
What is the current EBITDA of Nanosonics?Nanosonics' last 12 months EBITDA is $17M.
What is Nanosonics' EBITDA margin?Nanosonics' last 12 months EBITDA margin is 11%.
What is the current EV/EBITDA multiple of Nanosonics?Current EBITDA multiple of Nanosonics is 34.6x.
What is the current FCF of Nanosonics?Nanosonics' last 12 months FCF is $10M.
What is Nanosonics' FCF margin?Nanosonics' last 12 months FCF margin is 7%.
What is the current EV/FCF multiple of Nanosonics?Current FCF multiple of Nanosonics is 59.3x.
How many companies Nanosonics has acquired to date?Nanosonics hasn't acquired any companies yet (or none have been disclosed publicly).
In how many companies Nanosonics has invested to date?Nanosonics hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to Nanosonics

Lists including Nanosonics

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial